New ways to look at Alzheimer’s

Alzheimer; News from the web:

as the writer here details in a New England Journal of Medicine article, professionals, including physicians, can function competently even with clinical symptoms of Alzheimer’s disease. Just as each brain is unique, so is the disease progression and continued functioning of people with Alzheimer’s. Variability in the disease’s course is the norm, with some people staying stable for years, even without treatment. Yet, while we know that two people with the same type of kidney disease or breast cancer progress differently, with Alzheimer’s disease the overwhelming belief is that everyone ends up in a wheelchair, unable to recognize family and themselves.. While this is true in some, it is not the case for all.

Read all about it HERE

We can’t wait

Alzheimer; News from the web:

For this to hit the market: There are two drugs that have been developed by Salk Institute researchers to successfully treat Alzheimer’s in mice—and now, they have found that the very same drug compounds can also slow the aging process in the brains of healthy older mice.

Read all about it HERE

Subtypes of Alzheimer’s

Alzheimer; News from the web:

In a new study in JAMA Neurology, a team of neuroscientists at Mayo Clinic in Florida led by Melissa Murray, Ph.D., examined a key region of the brain and found that patterns of Alzheimer’s-related damage differed by subtype and age of onset.

The researchers say these observations could have important treatment implications.

Read all about it HERE

Alzheimer surprise drug

Alzheimer; News from the web:

Despite many promising leads, more than 120 drug treatments for Alzheimer’s disease have failed. But Cambridge-based biotech company Biogen revived hope on Tuesday with its announcement that it would seek Food and Drug Administration approval for a drug it abandoned earlier this year.

Read all about it HERE